Indian Pharmaceutical Company Doubles Profit

Oct. 23, 2009
Launch of new drugs in overseas markets boots Dr. Reddy's profit

Generic drug maker Dr. Reddy's Laboratories reported on Oct. 23 a doubling of net profit in the second quarter, aided by the launch of new drugs in overseas markets.

Net profit rose to 2.17 billion rupees (US$45 million) in the July-September quarter, from 1.05 billion rupees a year earlier.

Consolidated revenues rose 14% to 18.4 billion rupees in the quarter.

The Hyderabad-based firm said revenues rose in North America and Russia, led by volume growth in existing products and new drugs launched in the past year. Revenues in North America rose 36% and Russia by 26% but they dipped 13% in Europe due to pricing pressures.

During the quarter, Dr. Reddy's launched 39 new generic products and filed 24 new product registrations.

Copyright Agence France-Presse, 2009

Popular Sponsored Recommendations

Discover How an Eye Tracking Study Improves Training Procedures

Oct. 29, 2023
Did you know that your training processes can be streamlined by visualizing and analyzing key skills within your employee base? Find out how we use eye tracking to capture advanced...

Powering Up Productivity: The Transformative Power of AP Automation in Manufacturing

Oct. 25, 2023
Discover how AP Automation is revolutionizing the manufacturing industry, driving efficiency, cost savings, and security. In today's world, automation is the key to staying competitive...

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Legacy Phone Lines Are Draining Your Profits

Oct. 30, 2023
Copper wire phone line expenses that support emergency devices could be costing your company millions of dollars in wasteful overhead expenses. Rates have been skyrocketing while...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!